These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27608474)

  • 1. Probiotics and refractory chronic spontaneous urticaria.
    Nettis E; Di Leo E; Pastore A; Distaso M; Zaza I; Vacca M; Macchia L; Vacca A
    Eur Ann Allergy Clin Immunol; 2016 Sep; 48(5):182-7. PubMed ID: 27608474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with
    Drago L; Cioffi L; Giuliano M; Pane M; Amoruso A; Schiavetti I; Reid G; Ciprandi G; Propam Study Group
    J Immunol Res; 2022; 2022():3837418. PubMed ID: 35083341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
    Potter P; Mitha E; Barkai L; Mezei G; Santamaría E; Izquierdo I; Maurer M
    Pediatr Allergy Immunol; 2016 Feb; 27(1):55-61. PubMed ID: 26267219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic as an adjuvant therapy in chronic urticaria: a blinded randomized controlled clinical trial.
    Atefi N; Fallahpour M; Sharifi S; Ghassemi M; Roohaninasab M; Goodarzi A
    Eur Ann Allergy Clin Immunol; 2022 May; 54(3):123-130. PubMed ID: 33939347
    [No Abstract]   [Full Text] [Related]  

  • 5. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
    Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
    Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Refractoriness to an Up to Fourfold Dosage of Antihistamines in Isolated Chronic Spontaneous Urticaria.
    Wongjirattikarn R; Chaowattanapanit S; Foocharoen C; Sawanyawisuth K; Choonhakarn C; Julanon N; Utchariyaprasit E
    J Cutan Med Surg; 2022; 26(6):593-599. PubMed ID: 36172833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
    Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
    Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M; Yagami A; Togawa M; Saito A; Furue M
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory Effects of Lactobacillus salivarius LS01 and Bifidobacterium breve BR03, Alone and in Combination, on Peripheral Blood Mononuclear Cells of Allergic Asthmatics.
    Drago L; De Vecchi E; Gabrieli A; De Grandi R; Toscano M
    Allergy Asthma Immunol Res; 2015 Jul; 7(4):409-13. PubMed ID: 25749784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
    Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
    World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
    Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
    Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
    Yan S; Chen W; Wen S; Zhu W; Guo A; Chen X; Zhang C; Chen M; Zhang J; Su J; Zhao Y; He Y; Liu Z; Zhou H; Zeng W; Li J; Chen X
    J Dermatol Sci; 2014 Dec; 76(3):240-5. PubMed ID: 25455139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
    Altrichter S; Giménez-Arnau AM; Bernstein JA; Metz M; Bahadori L; Bergquist M; Brooks L; Ho CN; Jain P; Lukka PB; Rodriguez-Suárez E; Walton C; Datto CJ;
    Br J Dermatol; 2024 Jul; 191(2):187-199. PubMed ID: 38367194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
    Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
    Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report.
    Kim HS; Noh G
    J Med Case Rep; 2023 Jul; 17(1):341. PubMed ID: 37501211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria.
    Ayse Ornek S; Orcen C; Church MK; Kocaturk E
    Int Immunopharmacol; 2022 Nov; 112():109198. PubMed ID: 36115277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
    Ghazanfar MN; Holm JG; Thomsen SF
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.